Insider Transactions last 24 months for Regeneron Pharmaceuticals, Inc.  -  NSDQ: REGN

 
Transactions
All Buy Sell Option Exercise
Filer's Name
Relationship/
Title
Trans.
Date
Trans. Type
Ownership Type
Security Type
Shares
Price
Trans.
Value
Total Shares Owned
Ryan Arthur FDirector03/02/2026DSDirectCOM20$789.28$15,785.6017,703
Ryan Arthur FDirector03/02/2026DSDirectCOM20$788.96$15,779.2017,723
Ryan Arthur FDirector03/02/2026DSDirectCOM2$787.34$1,574.6817,743
Ryan Arthur FDirector03/02/2026DSDirectCOM7$786.61$5,506.2717,745
Ryan Arthur FDirector03/02/2026DSDirectCOM11$785.48$8,640.2817,752
Ryan Arthur FDirector03/02/2026DSDirectCOM9$784.48$7,060.3217,763
Ryan Arthur FDirector03/02/2026DSDirectCOM10$783.62$7,836.2017,772
Ryan Arthur FDirector03/02/2026DSDirectCOM2$782.62$1,565.2417,782
Ryan Arthur FDirector03/02/2026DSDirectCOM2$781.21$1,562.4217,784
Ryan Arthur FDirector03/02/2026DSDirectCOM3$780.69$2,342.0717,786
Ryan Arthur FDirector03/02/2026DSDirectCOM5$779.69$3,898.4517,789
Ryan Arthur FDirector03/02/2026DSDirectCOM2$778.30$1,556.6017,794
Ryan Arthur FDirector03/02/2026DSDirectCOM7$777.46$5,442.2217,796
Zoghbi Huda YDirector02/19/2026DSDirectCOM4$790.00$3,160.001,703
Zoghbi Huda YDirector02/19/2026DSDirectCOM56$785.61$43,994.161,707
Zoghbi Huda YDirector02/19/2026DSDirectCOM160$784.45$125,512.001,763
Zoghbi Huda YDirector02/19/2026DSDirectCOM220$783.29$172,323.801,923
Zoghbi Huda YDirector02/19/2026DSDirectCOM298$782.10$233,065.802,143
Zoghbi Huda YDirector02/19/2026DSDirectCOM209$781.28$163,287.522,441
Zoghbi Huda YDirector02/19/2026DSDirectCOM331$780.45$258,328.952,650
Zoghbi Huda YDirector02/19/2026DSDirectCOM208$779.55$162,146.402,981
Zoghbi Huda YDirector02/19/2026DSDirectCOM53$778.47$41,258.913,189
Zoghbi Huda YDirector02/19/2026DSDirectCOM50$775.50$38,775.003,242
Zoghbi Huda YDirector02/19/2026DSDirectCOM49$774.68$37,959.323,292
Zoghbi Huda YDirector02/19/2026AMDirectCOM1,638$376.69$617,018.223,341
1   2  3  4  5  6  7  8  9  10  Next Last  You are at page 1 of 16 pages
Transaction Type Key
First letter: A = Acquired, D = Disposed
Second letter:
A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust
Export Table Data to Excel Send to Excel